Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
AI generated
Jun 6, 2026, 08:21

Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention

Razieh Parizad, Researcher at Tabriz University of Medical Sciences, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Exploration of Neuroprotective Therapy, adding:

“Excited to share that our systematic review, ‘Factor XI inhibitors versus direct oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of efficacy and safety’, has been published in Exploration of Neuroprotective Therapy.

This systematic review evaluates the efficacy and safety of FXI inhibitors compared to DOACs for stroke prevention in atrial fibrillation.

Key findings include a significant reduction in major bleeding with FXI inhibitors, although DOACs were more effective in preventing stroke or systemic embolism.

I am grateful to express my sincere gratitude to Dr. Bata for his invaluable mentorship, guidance, and support throughout this work.

I am also grateful to my co-authors for their collaboration and contributions.”

Title: Factor XI inhibitors versus direct oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of efficacy and safety

Authors: Razieh Parizad, Juniali Hatwal, Haleh Bodagh, Akash Batta, Bishav Mohan

Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention

Stay updated on all scientific advances with Hemostasis Today.

Akash Batta Bishav Mohan DOACs Exploration of Neuroprotective Therapy Factor XI Haleh Bodagh Health Hematology Hemostasis Hemostasis News Hemostasis Today Juniali Hatwal Medicine Razieh Parizad
NewsFeed